Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats

作者：Xin Peng; Han Hao; Gao Danhong; Cui Wei; Yang Xuefeng; Ying Chenjiang; Sun Xiufa; Hao Liping^*

来源：Food and Chemical Toxicology, 2013, 52: 12-18.

DOI：10.1016/j.fct.2012.10.026

• Resveratrol
• Nonalcoholic fatty liver disease
• Fatty acid synthase
• Low density lipoprotein receptor
• Scavenger receptor class B type I
• Thyroid hormone receptor beta 1

Lipid metabolic disorders are widely considered to be one of the most critical and basic link in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to illustrate the alleviation function of resveratrol (Res) on NAFLD and the roles of hepatic fatty acid synthase (FAS), low density lipoprotein receptor (LDLr), scavenger receptor class B type I (SR-BI), and thyroid hormone receptor beta 1 (TR beta 1), which are the key molecules involved in lipid metabolism. Adult male Wistar rats were fed a normal diet or high fat/sucrose diet (HFS) with or without resveratrol for 13 weeks. HFS induced NAFLD formation and increased the lipids concentrations in serum and livers of rats, while noticeable improvement has been reached by Res intervention. Moreover, Res protected against HFS-induced decrease in hepatic LDLr and SR-BI mRNA and protein expressions, whereas TR beta 1 expressions were impervious with/without Res. Unexpectedly, hepatic FAS gene expressions were markedly diminished in NAFLD rats and were gradually increased by treatment with Res. These data indicate that the alleviative effects of Res on NAFLD are associated with up regulation of hepatic LDLr and SR-BI gene expressions, which provide new insights into the pharmacological targets of Res in the prevention of NAFLD.

• 出版日期2013-2
• 单位华中科技大学